Key facts
- It has raised $1.5M; the latest was Later Stage VC in Dec 2024.
- Notable investors include HSG (Hong Kong), Beijing Bohua Capital, Proxima Ventures (China), Hubei Provincial Science and Technology Investment Group, Shengyu Investment — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Vickor Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Vickor Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vickor Medical
Developer of intervention treatment solutions for structural cardiovascular diseases. The company's products include interventions for unexplained strokes and heart failures enabling a reduction in stroke and heart related disease incidents.
- Sector
- Healthcare
- HQ
- Wuhan, China
- Founded
- 2018
- Website
- vickor.com.cn/
- Ownership
- Privately Held (backing)
Vickor Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vickor Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vickor Medical in its N-PORT filings yet. We sweep new filings monthly.